Arkolith/Insider Trading/TARS/Form 4

Link William J PHD

DirectorTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$776K
Net Open-Market Flow
-$776K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)11K$61.97$655K109K
Jun 15, 2026Sell(S)2K$62.94$121K107K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001228684-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML